首页 > 市场调查报告书 > 医疗设备

药物递输设备呼吸器

市场调查报告书

商品编码

1471975

雾化器市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按类型、应用、最终用户和地理位置

Nebulizers Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, End User, and Geography

出版日期: 2024年03月12日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

2023年雾化器市场价值为81,588万美元，预计到2031年将达到131,557万美元；预计 2023-2031 年复合年增长率为 6.2%。

推动市场成长的关键因素是慢性呼吸道疾病盛行率的上升以及家庭护理环境对呼吸设备的需求不断增加正在推动市场的成长。然而，缺乏早期诊断和雾化治疗的高成本阻碍了雾化器市场的成长。

雾化器市场的市场趋势

雾化器技术的变化是由临床需求和新药理製剂的开发所推动的，这需要特殊的技术和性能特征。由于优化新药物输送的强大经济压力，创新输送设备（例如用于雾化治疗的跨黏膜药物输送系统）的开发规模已扩大。随着新的医学知识和有效的药物的出现，各种雾化器的治疗不断取得进展。雾化器技术的这些进步催生了使用微泵技术产生气雾剂的网状雾化器。除了雾化器的众多优点之外，越来越多的产品批准和开发可能会增强未来几年的需求。根据公司新闻稿，以下列出了一些主要的开发和批准：

2021 年 7 月，HCmed Innovations 的普莫金振动网状雾化器获得美国食品药物管理局 (FDA) 批准。它采用HCmed的先进技术，将液体药物转化为微小的气雾颗粒，可以直接输送到呼吸道，缓解呼吸道疾病的不适。此外，该设备便携且易于使用，使其成为需要吸入治疗的患者的便捷解决方案。

2020 年 6 月，Respira Technologies, Inc. 推出了 RespiRx 药物输送设备平台。这个新颖的平台是一款超便携式手持式振动网雾化器 (VMN)，用于各种适应症的局部和全身治疗，包括气喘和慢性阻塞性肺病。 RespiRx 提供预先填充药筒，其中包含一次性压电元件和悬浮在水溶液中的药物化合物。这种格式是为了方便患者而设计的，消除了由于清洁不当而导致的错误和误用。该药筒可进行编程以提供精确的剂量，并配备蓝牙技术来追踪剂量输送、测量资料并为医疗保健提供者收集电子医疗记录。

因此，各种市场参与者的技术进步和产品批准预计将在未来几年带来新的雾化器市场趋势。

雾化器市场：细分概述

雾化器市场根据类型、应用和最终用户进行细分。

按类型划分，市场分为喷射雾化器、超音波雾化器和网状雾化器。喷射雾化器细分市场在2022 年占据最大的市场份额。，以气雾剂的形式输送药物。它们专为一次性使用而设计，无需灭菌并降低污染风险。喷射雾化器常用于机械通气过程。这些雾化器在 CRD 治疗中的各种应用正在推动预测期内喷射雾化器的市场规模。

根据应用，市场分为慢性阻塞性肺病、气喘、囊性纤维化等。预计到2023 年，慢性阻塞性肺病(COPD) 细分市场将占据最大的雾化器市场。 (COPD) 患者罹患心臟病、肺癌和各种其他疾病的风险增加状况。据世界卫生组织 (WHO) 称，慢性阻塞性肺病是全球第三大死因。随着呼吸系统疾病负担的增加，对吸入疗法的需求也增加。此外，人们对居家照护治疗偏好的转变推动了手持式雾化器在慢性阻塞性肺病和气喘治疗中的应用。

根据最终用户，雾化器市场分为医院和诊所、急诊中心和家庭护理机构。医院和诊所细分市场在 2023 年占据最大市场份额，由于各种类型雾化器的医疗可用性以及这些设备在医院环境中的采用率不断增长，预计 2023 年至 2030 年复合年增长率最高。

雾化器市场：地理概况

全球雾化器市场报告的范围涵盖北美（美国、加拿大和墨西哥）、欧洲（德国、法国、义大利、英国、西班牙和欧洲其他地区）、亚太地区（中国、日本、印度、澳洲、韩国和亚太其他地区）、中东和非洲（南非、沙乌地阿拉伯、阿联酋以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地区）。 2023年，北美占据主要雾化器市场份额，其次是欧洲；亚太地区的市场在预测期内以最高的复合年增长率成长。这归因于新兴市场医疗保健基础设施的发展、医疗保健支出的增加、利润丰厚的报销政策以及该地区越来越重视更好的患者治疗结果。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 11 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第 12 章：竞争格局

关键参与者的热图分析
公司定位与专注

第 13 章：雾化器市场 - 主要公司概况

GE Healthcare
Agilent Technologies, Inc.
Koninklijke Philips N.V.
Drive DeVilbiss International
Omron Healthcare, Inc.
Vectura Group Ltd
PARI Medical Holding GmbH
Trudell Medical International
Terumo Corporation
GF Health Products

第 14 章：附录

简介目录

Product Code: TIPTE100001066

The nebulizers market was valued at US$ 815.88 million in 2023 and is expected to reach US$ 1315.57 million by 2031; it is estimated to record a CAGR of 6.2% during 2023-2031.

Key factors driving the market growth are the rising prevalence of chronic respiratory diseases and increasing demand for respiratory devices for home care settings are driving the growth of the market. However, the lack of early diagnosis and the high cost of nebulizing therapy hinder the nebulizers market growth.

Market Trends of the Nebulizers Market

Changes in nebulizer technology are driven by clinical needs and the development of new pharmacological agents, which require special techniques and performance characteristics. Due to strong economic pressures to optimize the delivery of newer medications, the development of innovative delivery devices, such as transmucosal drug delivery systems for nebulization therapies, has upscaled. With new medical knowledge and effective medicines, treatment with a wide range of nebulizers continues to advance. These advancements in nebulizer technology have led to the creation of mesh nebulizers that use micropump technology to produce aerosols. In addition to the numerous advantages of nebulizers, the growing number of product approvals and developments will likely strengthen the demand in the coming years. As per company press releases, a few major developments and approvals are listed below:

In July 2021, HCmed Innovations received US Food and Drug Administration (FDA) approval for Pulmogine Vibrating Mesh Nebulizer. It uses HCmed's advanced technology to convert liquid medication into tiny aerosol particles that can be directly delivered to the airways, relieving respiratory disease discomfort. Additionally, the device is portable and easy to use, making it a convenient solution for patients who require inhalation treatment.

In June 2020, Respira Technologies, Inc. launched its RespiRx drug delivery device platform. This novel platform is an ultra-portable handheld vibrating mesh nebulizer (VMN) for local and systemic treatment for various indications, including asthma and COPD. RespiRx offers a pre-filled cartridge that contains a disposable piezo element and the drug compound suspended in an aqueous solution. This format is designed for patients' convenience, eliminating errors and misuse due to improper cleaning. The cartridge is programmable to deliver precise doses and comes equipped with Bluetooth technology to track dose delivery, measure data, and collect electronic medical records for healthcare providers.

Therefore, such technological advancements by various market players and product approvals are anticipated to bring new nebulizers market trends in the coming years.

Nebulizers Market: Segmental Overview

The nebulizers market is segmented on the basis of type, application, and end- user.

By type, the market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers. The jet nebulizers segment held the largest market share in 2022. The Mesh Nebulizers segment is projected to register the highest CAGR from 2023 to 2031. Jet nebulizers are affordable and easy-to-use devices that deliver medication in the form of aerosol. They are designed for one-time use, eliminating the need for sterilization and reducing contamination risk. Jet nebulizers are commonly used during mechanical ventilation. The various application of these nebulizers in treatment of CRD is propelling the jet nebulizers market size during the forecast period.

The market, by application, is segmented into COPD, asthma, cystic fibrosis, and others. The COPD segment is anticipated to hold the largest nebulizers market share in 2023. The asthma segment is projected to grow with the highest CAGR from 2023 to 2031. People with COPD are at increased risk of developing heart disease, lung cancer and a variety of other conditions. According to the World Health Organization (WHO), COPD is the third leading cause of death globally. The demand for inhalation therapies is also increasing with the increase in the burden of respiratory diseases. Additionally, the shift in preference for home care treatments fuels the utilization of handheld nebulizers for the management of COPD and asthma.

Based on end- user, the nebulizers market is segmented into hospitals and clinics, emergency centers, and home care settings. The hospitals and clinics segment held the largest share of the market in 2023 and is expected to register the highest CAGR from 2023 to 2030 owing to the medical availability of various types of nebulizers and the growing adoption rate of these devices in hospital settings.

Nebulizers Market: Geographical Overview

The scope of the global nebulizers market report entails North America (the US, Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America held a major nebulizers market share in 2023, followed by Europe; the market in Asia Pacific region is growing with the highest CAGR during the forecast period. This is attributed to developing healthcare infrastructure in emerging markets, rising healthcare expenditure, lucrative reimbursement policies, and increasing emphasis on better patient outcomes in the region.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Nebulizers Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Nebulizers Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Nebulizers Market - Global Market Analysis

6.1 Nebulizers - Global Market Overview
6.2 Nebulizers - Global Market and Forecast to 2030

7. Nebulizers Market - Revenue Analysis (USD Million) - By Type, 2020-2030

7.1 Overview
7.2 Jet Nebulizers
7.3 Ultrasonic Nebulizers
7.4 Mesh Nebulizers

8. Nebulizers Market - Revenue Analysis (USD Million) - By Application , 2020-2030

8.1 Overview
8.2 COPD
8.3 Asthma
8.4 Cystic Fibrosis
8.5 Others

9. Nebulizers Market - Revenue Analysis (USD Million) - By End-User, 2020-2030

9.1 Overview
9.2 Hospitals and Clinics
9.3 Emergency Center
9.4 Home Care Setting

10. Nebulizers Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Nebulizers Market Overview
- 10.1.2 North America Nebulizers Market Revenue and Forecasts to 2030
- 10.1.3 North America Nebulizers Market Revenue and Forecasts and Analysis - By Type
- 10.1.4 North America Nebulizers Market Revenue and Forecasts and Analysis - By Application
- 10.1.5 North America Nebulizers Market Revenue and Forecasts and Analysis - By End-User
- 10.1.6 North America Nebulizers Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.6.1 United States Nebulizers Market
    - 10.1.6.1.1 United States Nebulizers Market, by Type
    - 10.1.6.1.2 United States Nebulizers Market, by Application
    - 10.1.6.1.3 United States Nebulizers Market, by End-User
  - 10.1.6.2 Canada Nebulizers Market
    - 10.1.6.2.1 Canada Nebulizers Market, by Type
    - 10.1.6.2.2 Canada Nebulizers Market, by Application
    - 10.1.6.2.3 Canada Nebulizers Market, by End-User
  - 10.1.6.3 Mexico Nebulizers Market
    - 10.1.6.3.1 Mexico Nebulizers Market, by Type
    - 10.1.6.3.2 Mexico Nebulizers Market, by Application
    - 10.1.6.3.3 Mexico Nebulizers Market, by End-User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Nebulizers Market - Key Company Profiles

13.1 GE Healthcare
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies